TRAVERE THERAPEUTICS, INC. Fair Value Adjustment of Warrants
TRAVERE THERAPEUTICS, INC. (TVTX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-02-24
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-12-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-03-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2019 was $0.00.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2017 was $4.49M.
- TRAVERE THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2016 was -$1.66M, a 104.97% decline from fiscal 2015.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-24 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | -$4.43M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | -$4.43M derived: sum of 3 quarters · filed 2020-02-24 | $4.47M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-07-06 | -$4.43M derived: sum of 2 quarters · filed 2020-02-24 | $4.47M derived: sum of 3 quarters · filed 2020-02-24 | $5.75M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | -$4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $4.47M derived: sum of 2 quarters · filed 2020-02-24 | $5.75M derived: sum of 3 quarters · filed 2020-02-24 | $4.49M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $8.90M 10-Q · filed 2018-11-01 | $10.18M derived: sum of 2 quarters · filed 2018-11-01 | $8.92M 10-Q · filed 2018-11-01 | $2.42M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $1.28M 10-Q · filed 2018-08-03 | $20.00K 10-Q · filed 2018-08-03 | -$6.48M derived: sum of 3 quarters · filed 2019-02-26 | $3.64M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$1.26M 10-Q · filed 2018-07-06 | -$7.76M derived: sum of 2 quarters · filed 2019-02-26 | $2.36M derived: sum of 3 quarters · filed 2019-02-26 | $11.43M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.62M derived: sum of 2 quarters · filed 2019-02-26 | $12.69M derived: sum of 3 quarters · filed 2019-02-26 | -$1.66M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $10.13M 10-Q · filed 2017-11-07 | $19.19M derived: sum of 2 quarters · filed 2017-11-07 | $4.85M 10-Q · filed 2017-11-07 | $1.98M derived: sum of 4 quarters · filed 2018-07-06 | |||
| 2016-06-30 | $9.06M 10-Q · filed 2017-08-09 | -$5.28M 10-Q · filed 2017-08-09 | -$8.15M derived: sum of 3 quarters · filed 2018-07-06 | -$38.14M derived: sum of 4 quarters · filed 2018-07-06 | |||
| 2016-03-31 | -$14.34M 10-Q · filed 2017-05-05 | -$17.21M derived: sum of 2 quarters · filed 2018-07-06 | -$47.20M derived: sum of 3 quarters · filed 2018-07-06 | -$17.79M derived: sum of 4 quarters · filed 2018-07-06 | |||
| 2015-12-31 | -$2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | -$32.86M derived: sum of 2 quarters · filed 2018-07-06 | -$3.45M derived: sum of 3 quarters · filed 2018-07-06 | $33.31M 10-K · filed 2018-07-06 | |||
| 2015-09-30 | -$29.99M 10-Q · filed 2016-11-04 | -$573.00K derived: sum of 2 quarters · filed 2016-11-04 | $36.18M 10-Q · filed 2016-11-04 | $45.69M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $29.42M 10-Q · filed 2016-08-05 | $66.17M 10-Q · filed 2016-08-05 | $75.68M derived: sum of 3 quarters · filed 2017-03-01 | $69.32M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $36.75M 10-Q · filed 2016-05-05 | $36.75M 10-Q · filed 2015-05-11 | $46.26M derived: sum of 2 quarters · filed 2017-03-01 | $39.90M derived: sum of 3 quarters · filed 2017-03-01 | $6.92M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $9.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.15M derived: sum of 2 quarters · filed 2017-03-01 | -$29.83M derived: sum of 3 quarters · filed 2017-03-01 | $23.79M 10-K · filed 2017-03-01 | $23.79M 10-K · filed 2015-03-11 | ||
| 2014-09-30 | -$6.36M 10-Q · filed 2015-11-06 | -$6.36M 10-Q · filed 2014-11-13 | -$39.34M derived: sum of 2 quarters · filed 2015-11-06 | $14.28M 10-Q · filed 2015-11-06 | $14.28M 10-Q · filed 2014-11-13 | $16.18M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | -$32.98M 10-Q · filed 2015-08-10 | $20.64M 10-Q · filed 2015-08-10 | $22.54M derived: sum of 3 quarters · filed 2016-02-26 | $28.34M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | $53.61M 10-Q · filed 2015-05-11 | $55.52M derived: sum of 2 quarters · filed 2016-02-26 | $61.32M derived: sum of 3 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $7.70M derived: sum of 2 quarters · filed 2016-02-26 | $10.10M 10-K · filed 2016-02-26 | $10.10M 10-K · filed 2015-03-11 | |||
| 2013-09-30 | $5.80M 10-Q · filed 2014-11-13 | $8.20M 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |